Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043
Durvalumab 和 guadecitabine 治疗晚期透明细胞肾细胞癌：Ib/II 期研究 BTCRC-GU16-043 的结果
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-024-45216-z
Yousef Zakharia, Eric A Singer, Satwik Acharyya, Rohan Garje, Monika Joshi, David Peace, Veera Baladandayuthapani, Annesha Majumdar, Xiong Li, Claudia Lalancette, Ilona Kryczek, Weiping Zou, Ajjai Alva
